Former CEO Shuldman Demands Board Action at TransAct

What happened

In an open letter dated April 23, 2026, former CEO and current shareholder Bart Shuldman publicly called on TransAct's board to address the company’s underperformance, likely pushing for a sale or other strategic moves. This activist intervention comes as the company navigates a delicate BOHA! software migration and a 19% tariff headwind, with the stock trading near $3.50. Shuldman’s letter underscores growing frustration among insiders with the pace of value creation, aligning with the DeepValue report’s view that TACT is in a transition year with limited near-term catalysts. While management has kept a “strategic review” active, the letter increases the probability of a near-term liquidity event or sale, which could unlock value but also distract from operational execution. The board's response will be critical; if they resist, the stock may slide further on governance concerns.

Implication

Investors should monitor board response and any sale process developments. If a sale emerges, upside to $4-$5 is possible; if not, the stock remains range-bound with execution risk until BOHA! migration completes in 2027.

Thesis delta

The previous thesis waited for gross margin and BOHA! recurring breadth proof. Shuldman’s public pressure introduces a governance catalyst that could force a sale or restructuring before those operational proofs are achieved. This shifts the timeline from 'wait for 2027' to 'activist timeline within 2026,' but does not eliminate the fundamental risk that a sale might occur at a discount if operations are still weak.